Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAF V600E mutation and high expression of PD-L1 in Rosai-Dorfman disease: case report and review of the literature.

Journal of hematopathology - 1 Dec 2024

Moen Farnoush M, Youssef Mariam M, Shukla Mihir, Nierodzik Mary Lynn, Mayerhoefer Marius E, Park Christopher

Abstract excerpt

BRAF V600E mutations are frequently found in histiocytic/dendritic cell neoplasms such as Erdheim-Chester disease (ECD) and Langerhans cell histiocytosis (LCH), but few reports have also described BRAF mutations in Rosai-Dorfman disease (RDD), and even these cases may predominantly represent mixed histiocytosis. BRAF mutations have been studied in histiocytic/dendritic cell neoplasms and described to be...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Substitution
Share to Mutation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation, Missense

Share to Proto-Oncogene Proteins B-raf

Source

Open in PubMed Open full text

Identifiers

PMID: 39592527
DOI: 10.1007/s12308-024-00611-9
PMCID: PMC11635026

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAF V600E mutation and high expression of PD-L1 in Rosai-Dorfman disease: case report and review of the literature.PMID 39592527Read ↗

Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.Semantic proximity Read ↗

Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.Semantic proximity Read ↗

How I Diagnose Rosai-Dorfman Disease.Semantic proximity Read ↗

Histiocytic disorders: insights into novel biology and implications for therapy of Langerhans cell histiocytosis and Erdheim-Chester disease.Semantic proximity Read ↗

Molecular characterization of the histiocytoses: Neoplasia of dendritic cells and macrophages.Semantic proximity Read ↗

Cyclin D1 expression and novel mutational findings in Rosai‐Dorfman diseaseSemantic proximity Read ↗

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.Semantic proximity Read ↗

Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease.Semantic proximity Read ↗

Malignant Histiocytosis Comprises a Phenotypic Spectrum That Parallels the Lineage Differentiation of Monocytes, Macrophages, Dendritic Cells, and Langerhans Cells.Semantic proximity Read ↗

Biological and therapeutic implications of the BRAF pathway in histiocytic disorders.Semantic proximity Read ↗

Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.Semantic proximity Read ↗

Molecular Pathogenesis of the Histiocytic and Dendritic Cell Neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.